Exosomes in Chronic Myeloid Leukemia: Are We Reading a New Reliable Message?

Acta Haematol. 2020;143(5):509-510. doi: 10.1159/000505088. Epub 2020 Jan 9.

Authors

Simona Bernardi¹, Michele Malagola², Nicola Polverelli², Domenico Russo²

Affiliations

¹ Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, Spedali Civili of Brescia, University of Brescia, Brescia, Italy, simona.bernardi@unibs.it.
² Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, Spedali Civili of Brescia, University of Brescia, Brescia, Italy.

PMID: 31922494
DOI: 10.1159/000505088

No abstract available

Publication types

Letter

MeSH terms

Exosomes / metabolism*
Fusion Proteins, bcr-abl / genetics
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*
Neoplasm, Residual
Polymerase Chain Reaction
Protein Kinase Inhibitors / therapeutic use

Substances

BCR-ABL1 fusion protein, human
Protein Kinase Inhibitors
Fusion Proteins, bcr-abl